ICD 10 Code for Anemia in Pregnancy: O99.0 Guide

The ICD-10 code for anemia in pregnancy is O99.0 (Anemia complicating pregnancy, childbirth and the puerperium). If you’re a clinician or coder looking for a quick answer, that’s it—but the real challenge is selecting the correct trimester-specific subcode and knowing when to use O99.0 versus a standalone anemia code like D50.9. Getting this wrong leads to claim denials, undercoding, and gaps in epidemiological data that affect maternal health research.

This guide breaks down the complete O99.0 code family, explains when each subcode applies, walks through the diagnostic thresholds that trigger coding, and covers the clinical management that supports proper documentation. Whether you’re an OB/GYN, a midwife, a hematologist consulted on a complex case, or a clinical coder trying to get this right, this is the reference you need.

O99.0 Subcodes: The Full Breakdown by Trimester

ICD-10-CM requires trimester-specific coding for anemia in pregnancy. The base code O99.0 should never be submitted alone on a claim—you need the fifth character to specify timing. Here’s the complete family:

Coding tip: O99.019 (unspecified trimester) is a red flag for auditors. Use it only when documentation genuinely doesn’t indicate gestational age—which should be rare in modern obstetric care. If the chart says “26 weeks,” code O99.012. Don’t default to unspecified out of convenience.

When to Use O99.0 vs. a Standalone Anemia Code

This is where many coders get tripped up. O99.0 is not a standalone code. ICD-10-CM guidelines instruct you to use an additional code from the D50–D64 range to identify the specific type of anemia. The O99.0 code tells the payer “this anemia is complicating the pregnancy.” The D-code tells them what kind of anemia it is.

Common Pairing Examples

Key distinction: If a pregnant patient has pre-existing anemia that doesn’t affect or complicate the pregnancy, some coders argue you only need the D-code. But in practice, most payers and auditors expect the O99.0 code when anemia is diagnosed during pregnancy, regardless of whether it was pre-existing. When in doubt, code both—it supports medical necessity for monitoring and treatment.

Diagnostic Thresholds: When Does Anemia in Pregnancy Actually Start?

The WHO and ACOG use slightly different hemoglobin cutoffs, and the thresholds shift across trimesters because of physiological hemodilution—plasma volume increases by about 50% during pregnancy while red cell mass increases by only ~25%. This predictable drop in hemoglobin concentration peaks around 28–34 weeks.

Notice the second trimester threshold is lower—that’s intentional. Hemodilution is most pronounced mid-pregnancy, so a hemoglobin of 10.7 g/dL at 24 weeks isn’t necessarily pathological. But the same value at 10 weeks is a problem.

Severe anemia in pregnancy is typically defined as hemoglobin below 7.0 g/dL. At this level, maternal and fetal risks climb sharply—cardiac decompensation, intrauterine growth restriction, preterm delivery, and increased peripartum hemorrhage risk all become real concerns.

Causes of Anemia in Pregnancy: Beyond Iron Deficiency

Iron-deficiency anemia (IDA) accounts for roughly 75% of all anemia in pregnancy worldwide, according to WHO data. But clinicians who stop investigating after finding a low ferritin miss important diagnoses. Here’s the full differential:

Common Causes

• Iron deficiency — Increased iron demand (about 1,000 mg total over pregnancy), poor dietary intake, malabsorption (celiac disease, gastric bypass, IBD)
• Physiological hemodilution — Not true anemia; disproportionate plasma expansion. Usually self-limited and doesn’t require treatment
• Folate deficiency — More common in populations without folic acid fortification; presents as macrocytic anemia (MCV > 100 fL)

Less Common but Clinically Important Causes

• Vitamin B12 deficiency — Consider in vegetarians/vegans, patients with pernicious anemia, or post-bariatric surgery
• Thalassemia trait — Alpha or beta thalassemia trait causes microcytic anemia with a normal or elevated RBC count. Ferritin is typically normal. Often misdiagnosed as IDA
• Sickle cell disease — Pregnancy exacerbates chronic hemolytic anemia and increases crisis risk
• Anemia of chronic disease — Seen with chronic infections, autoimmune disorders, or renal insufficiency
• Acute blood loss — Placental abruption, placenta previa, or other antepartum hemorrhage

A frequent clinical pitfall: treating microcytic anemia in a Southeast Asian or Mediterranean patient with iron supplements for months without checking a hemoglobin electrophoresis. If the MCV is disproportionately low relative to the hemoglobin (Mentzer index < 13), think thalassemia trait first.

Diagnostic Workup: What to Order and When

Every pregnant patient should have a CBC at the first prenatal visit and again at 24–28 weeks (coinciding with the glucose tolerance test is convenient). ACOG recommends this two-screen approach as standard of care.

First-Line Labs

• CBC with differential — Hemoglobin, hematocrit, MCV, RDW, RBC count
• Serum ferritin — The single best marker of iron stores. A ferritin < 30 ng/mL in pregnancy indicates depleted iron stores, even if hemoglobin is still normal. Below 15 ng/mL is definitive iron deficiency
• Peripheral blood smear — When the CBC raises questions (abnormal indices, unexpected findings)

Second-Line Labs (Based on Initial Results)

• Transferrin saturation and TIBC — Helpful when ferritin is equivocal (30–100 ng/mL) since ferritin is an acute-phase reactant that can be falsely elevated with infection or inflammation
• Reticulocyte count — Assesses bone marrow response; helpful to distinguish production problems from destruction/loss
• Serum folate and vitamin B12 — When MCV is elevated (> 100 fL)
• Hemoglobin electrophoresis — When microcytic anemia doesn’t respond to iron, or in patients with family history or ethnic predisposition to hemoglobinopathies
• Soluble transferrin receptor (sTfR) — Useful when trying to distinguish IDA from anemia of chronic disease in the setting of elevated inflammatory markers

For documentation and coding purposes, make sure lab results and clinical decision-making are explicitly tied in the chart. A note that says “anemia—start iron” is weaker documentation than “Hgb 9.8 g/dL at 30 weeks, ferritin 8 ng/mL, consistent with iron-deficiency anemia complicating third trimester pregnancy (O99.013, D50.9). Starting ferrous sulfate 325 mg BID with vitamin C, recheck CBC in 4 weeks.”

Treatment: What Works, What Doesn’t, and When to Escalate

Oral Iron Therapy (First-Line for Mild to Moderate IDA)

Ferrous sulfate 325 mg (65 mg elemental iron) taken once or twice daily remains first-line. Recent evidence, including a landmark study published in The Lancet Haematology (2020), suggests that alternate-day dosing may actually improve fractional iron absorption compared to daily dosing, due to hepcidin-mediated regulation. In practice, many patients tolerate alternate-day dosing better with fewer GI side effects.

• Take on an empty stomach with vitamin C (250 mg) to enhance absorption
• Avoid concurrent intake of calcium, antacids, tea, coffee, and dairy—all inhibit iron absorption
• Expect hemoglobin to rise by approximately 1 g/dL every 2–3 weeks with adequate therapy
• Continue for 3 months after hemoglobin normalizes to replenish stores

If hemoglobin hasn’t improved by 2–4 weeks, reassess: Is the patient actually taking the pills? Is there malabsorption? Is the diagnosis wrong (thalassemia trait won’t respond to iron)?

Intravenous (IV) Iron (When Oral Fails or Can’t Wait)

IV iron is indicated when:

• Oral iron is not tolerated (severe nausea, constipation, non-compliance)
• Oral iron has failed after 2–4 weeks of adequate trial
• Malabsorption is documented or suspected
• Hemoglobin is < 8.0 g/dL in the second or third trimester with insufficient time for oral correction
• The patient has a history of bariatric surgery or IBD

Ferric carboxymaltose (Injectafer) and iron sucrose (Venofer) are the most commonly used formulations in pregnancy. Ferric carboxymaltose has the advantage of requiring fewer infusions—often a single 750 mg dose repeated once at one week—while iron sucrose typically requires 5 sessions of 200 mg each.

IV iron is generally considered safe in the second and third trimesters. First-trimester use is less studied, and most guidelines recommend avoiding it unless absolutely necessary. Iron dextran is largely avoided due to higher anaphylaxis risk.

Blood Transfusion (Reserved for Severe Cases)

Transfusion is appropriate when hemoglobin falls below 7.0 g/dL with symptoms (tachycardia, dyspnea at rest, hemodynamic instability) or when acute hemorrhage demands immediate correction. In stable patients, even hemoglobin values of 7–8 g/dL can often be managed with IV iron if there’s adequate time before delivery.

Folate and B12 Supplementation

All pregnant women should take at least 400 mcg of folic acid daily (600 mcg is recommended by ACOG). Women with documented folate-deficiency anemia may need 1–5 mg daily. B12 deficiency requires parenteral supplementation (1,000 mcg IM weekly initially) if malabsorption is the cause.

Maternal and Fetal Risks: Why This Matters Beyond Coding

Anemia in pregnancy isn’t just a lab abnormality. The clinical consequences are well-documented and dose-dependent—the lower the hemoglobin, the higher the risk:

• Preterm birth: A 2013 meta-analysis in the BMJ found that anemia in the first trimester increased preterm birth risk by 63% (OR 1.63, 95% CI 1.33–2.01)
• Low birth weight: Hemoglobin below 9 g/dL is associated with significantly increased risk of small-for-gestational-age infants
• Postpartum hemorrhage: Anemic women have less physiological reserve and are more likely to require transfusion if hemorrhage occurs
• Maternal mortality: WHO estimates that severe anemia contributes to approximately 20% of maternal deaths globally, primarily in low-resource settings
• Neonatal iron deficiency: Severe maternal IDA can compromise fetal iron stores, affecting neonatal neurodevelopment
• Postpartum depression: Emerging evidence links peripartum anemia with increased rates of postpartum depression and impaired bonding

Documentation Tips That Prevent Claim Denials

Proper coding starts with proper documentation. Here’s what auditors and coders need from the clinician’s note:

• Specify the trimester. Don’t make the coder guess. State the gestational age clearly
• Name the type of anemia. “Anemia” alone forces the coder to use unspecified codes. “Iron-deficiency anemia” or “anemia due to acute blood loss” gives them the specificity to code accurately
• Link the anemia to the pregnancy. A simple phrase like “complicating pregnancy” or “anemia of pregnancy” triggers the O99.0 code. Without it, coders may default to D50.9 alone, which doesn’t capture the obstetric context
• Document severity. Note whether the anemia is mild, moderate, or severe. This supports medical necessity for IV iron or transfusion
• Record response to treatment. Follow-up hemoglobin values and clinical response support continued coding and treatment authorization

Global Prevalence: The Scale of the Problem

Anemia in pregnancy is a global public health challenge. WHO estimates that 36.5% of pregnant women worldwide are anemic—that’s roughly 32 million pregnancies annually. The burden is not evenly distributed:

• South Asia: ~52% prevalence
• Sub-Saharan Africa: ~46% prevalence
• North America/Europe: ~15–25% prevalence

Even in high-income countries, iron deficiency without anemia (depleted stores with normal hemoglobin) affects up to 40% of pregnant women—and is often undiagnosed because ferritin isn’t routinely checked.

Frequently Asked Questions

Can I use O99.0 for physiological anemia of pregnancy?

No. Physiological hemodilution—where hemoglobin drops mildly due to normal plasma expansion—is a normal finding, not a complication. O99.0 is reserved for pathological anemia that complicates the pregnancy. If the hemoglobin is above the trimester-specific threshold and iron stores are adequate, this is normal physiology and doesn’t warrant an anemia code.

Does O99.0 require a secondary code?

Yes. ICD-10-CM coding guidelines state to “use additional code” to identify the specific anemia (D50–D64 range). Submitting O99.013 without a secondary D-code is technically incomplete. Many payers will process it, but it’s not best practice and may trigger queries.

What’s the difference between O99.0 and O90.81 (anemia of the puerperium)?

O90.81 specifically covers anemia that develops during the postpartum period and was not present before delivery. O99.03 covers anemia that was present during pregnancy and continues into the puerperium. If a patient was anemic during pregnancy and remains anemic postpartum, O99.03 is correct. If she develops new anemia postpartum (e.g., from postpartum hemorrhage), O90.81 is more appropriate, paired with the relevant D-code.

Should I screen all pregnant patients for iron deficiency, or just anemia?

ACOG currently recommends screening for anemia (via CBC) but stops short of recommending universal ferritin screening. However, the U.S. Preventive Services Task Force (USPSTF) has acknowledged insufficient evidence to recommend for or against routine iron supplementation in non-anemic pregnant women. Many hematologists and maternal-fetal medicine specialists argue that ferritin should be checked at the first prenatal visit for all patients. A ferritin below 30 ng/mL warrants supplementation even with a normal hemoglobin.

When should I refer a pregnant patient with anemia to hematology?

Consider referral when: hemoglobin doesn’t respond to 4 weeks of appropriate iron therapy, anemia is severe (< 7 g/dL), you suspect a hemoglobinopathy or bone marrow disorder, the patient has a history of hemolytic anemia, or the clinical picture doesn’t fit a nutritional deficiency. Sickle cell disease in pregnancy warrants co-management with hematology from the outset.

Key Takeaways for Clinicians

• The ICD-10 code for anemia in pregnancy is O99.0, with trimester-specific subcodes (O99.011–O99.019, O99.02, O99.03)
• Always pair O99.0 with a secondary code from D50–D64 to specify the type of anemia
• Hemoglobin thresholds for diagnosing anemia vary by trimester—don’t apply a single cutoff across all of pregnancy
• Check serum ferritin early; it catches iron depletion before hemoglobin drops
• Oral iron remains first-line, but switch to IV iron if there’s no response by 2–4 weeks or if anemia is moderate-to-severe in late pregnancy
• Document the type of anemia, the trimester, and the link to pregnancy explicitly—this is what makes the difference between clean claims and denials
• Don’t forget the differential: thalassemia trait, B12 deficiency, and anemia of chronic disease are all in play, and iron won’t fix them